Compare Unichem Lab with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CIPLA UNICHEM LAB/
CIPLA
 
P/E (TTM) x -3,667.6 28.0 - View Chart
P/BV x 0.7 4.0 17.4% View Chart
Dividend Yield % 1.6 0.6 288.5%  

Financials

 UNICHEM LAB   CIPLA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
CIPLA
Mar-21
UNICHEM LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs360879 41.0%   
Low Rs122411 29.6%   
Sales per share (Unadj.) Rs175.4237.6 73.8%  
Earnings per share (Unadj.) Rs4.929.8 16.5%  
Cash flow per share (Unadj.) Rs16.942.2 40.0%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Avg Dividend yield %1.70.8 214.1%  
Book value per share (Unadj.) Rs362.0226.7 159.7%  
Shares outstanding (eoy) m70.41806.46 8.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.42.7 50.6%   
Avg P/E ratio x48.921.6 225.9%  
P/CF ratio (eoy) x14.215.3 93.3%  
Price / Book Value ratio x0.72.8 23.4%  
Dividend payout %81.216.8 483.8%   
Avg Mkt Cap Rs m16,954519,826 3.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3,07032,518 9.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,351191,596 6.4%  
Other income Rs m5022,698 18.6%   
Total revenues Rs m12,853194,294 6.6%   
Gross profit Rs m91141,841 2.2%  
Depreciation Rs m84410,031 8.4%   
Interest Rs m511,607 3.2%   
Profit before tax Rs m51832,901 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1728,888 1.9%   
Profit after tax Rs m34724,013 1.4%  
Gross profit margin %7.421.8 33.8%  
Effective tax rate %33.127.0 122.5%   
Net profit margin %2.812.5 22.4%  
BALANCE SHEET DATA
Current assets Rs m13,773132,095 10.4%   
Current liabilities Rs m5,05845,916 11.0%   
Net working cap to sales %70.645.0 156.9%  
Current ratio x2.72.9 94.7%  
Inventory Days Days15568 228.4%  
Debtors Days Days7407 11,266.9%  
Net fixed assets Rs m17,344116,277 14.9%   
Share capital Rs m1411,613 8.7%   
"Free" reserves Rs m25,350181,232 14.0%   
Net worth Rs m25,491182,844 13.9%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m31,118248,372 12.5%  
Interest coverage x11.121.5 51.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.40.8 51.5%   
Return on assets %1.310.3 12.4%  
Return on equity %1.413.1 10.4%  
Return on capital %2.217.7 12.6%  
Exports to sales %82.831.3 264.5%   
Imports to sales %14.410.9 132.1%   
Exports (fob) Rs m10,22459,951 17.1%   
Imports (cif) Rs m1,78020,911 8.5%   
Fx inflow Rs m10,22468,051 15.0%   
Fx outflow Rs m1,78020,911 8.5%   
Net fx Rs m8,44447,140 17.9%   
CASH FLOW
From Operations Rs m33137,552 0.9%  
From Investments Rs m-736-23,872 3.1%  
From Financial Activity Rs m-1,212-13,299 9.1%  
Net Cashflow Rs m-1,541509 -302.6%  

Share Holding

Indian Promoters % 50.9 14.3 355.7%  
Foreign collaborators % 0.0 21.8 -  
Indian inst/Mut Fund % 10.6 45.8 23.2%  
FIIs % 1.5 24.8 6.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 63.9 76.8%  
Shareholders   33,892 410,831 8.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA  LUPIN  AUROBINDO PHARMA  DR. REDDYS LAB  CADILA HEALTHCARE  



Today's Market

4 Reasons Why Sensex Surged 1,016 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 8, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS